ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies

Dianzani, Chiara; Monge, Chiara

Back to results

Università degli Studi di Torino

ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies

dc:creator Dianzani, Chiara; Monge, Chiara

dc:date2024

Degree

thesis:*

Grantor dc:publisher: Università degli Studi di Torino
Year dc:date: 2024

Author and committee

dc:creator, dc:contributor.*

Authors dc:creator: Dianzani, Chiara
Monge, Chiara

Subjects

dc:subject × 1

Settore BIO/14 - Farmacologia

Rights

dc:rights

Statement dc:rights: info:eu-repo/semantics/openAccess
Language dc:language: eng

Identifiers

dc:identifier.*

Handle dc:identifier: https://hdl.handle.net/2318/2017073
OAI identifier oai:identifier: oai:iris.unito.it:2318/2017073

Chain of custody

source

Harvested from: Università di Torino
Base URL: iris.unito.it/oai/driver
Last updated: 2026-07-24
Source record: OAI-PMH GetRecord

related terms

citation

Dianzani, Chiara; Monge, Chiara. ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies. Università degli Studi di Torino, 2024. https://hdl.handle.net/2318/2017073

ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies

Degree

Author and committee

Subjects

Rights

Identifiers

Chain of custody

More from Università di Torino